
Itraconazole
Itraconazole treats serious fungal infections such as blastomycosis and histoplasmosis and, as Sporanox capsules, fungal nail infections. A Cochrane review found high-quality evidence that azole antifungals beat placebo for toenail fungus, though terbinafine was probably more effective. Its boxed warning covers heart failure and many dangerous drug interactions; grapefruit juice is rated moderate and Saccharomyces boulardii high.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with blastomycosis, histoplasmosis or aspergillosis, or with lab-confirmed fungal nail infection, whose prescriber has reviewed their heart health and every other medicine
Common dosing range
Set by your prescriber. The Sporanox label lists 200 mg once daily for blastomycosis and histoplasmosis (up to 400 mg a day), 200 to 400 mg a day for aspergillosis, 200 mg once daily for 12 weeks for toenail infection, and two 1-week pulses of 200 mg twice daily for fingernail infection. Tolsura uses different doses (130 mg once daily to start)
When to expect effects
For blastomycosis and histoplasmosis the label says that in open-label studies most signs and symptoms responded within the first 2 weeks, and treatment for deep fungal infections lasts at least 3 months; for toenails, the mean time to overall success in label trials was about 10 months, as the nail grows out
Watch out for
Boxed warning: can cause or worsen congestive heart failure (not for nail infection in anyone with heart failure or a history of it), and many drugs are contraindicated because it raises their levels, risking dangerous heart rhythms. Rare serious liver injury, sometimes in the first week
What is it
Itraconazole is a prescription azole antifungal taken by mouth. It is sold as Sporanox 100 mg capsules and generic itraconazole capsules, as Tolsura 65 mg capsules, and as a generic oral solution. The Sporanox capsule label approves it for blastomycosis, histoplasmosis and aspergillosis (when amphotericin B has failed or is not tolerated), and for fungal nail infections (onychomycosis) of the toenails and fingernails. Tolsura is approved for the same deep fungal infections but not for nail infections, and the oral solution is approved for thrush of the mouth and esophagus. The forms are not interchangeable. Its labels carry a boxed warning for congestive heart failure and for dangerous drug interactions.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
fungal nail infection of the toenails Strong Evidence | Large versus placebo; smaller than terbinafine | Adults with lab-confirmed dermatophyte toenail infection and no heart failure | Cure was assessed months after treatment ended (72 weeks in LION) as the nail grows out |
blastomycosis and histoplasmosis Limited Evidence | Success in 81% to 90% of treated patients, without a control group | Adults with non-meningeal, non-life-threatening blastomycosis or histoplasmosis | Successful patients were treated for a median of 6.2 months (blastomycosis) and 9.0 months (histoplasmosis) |
fungal nail infection of the toenails
- Effect
- Large versus placebo; smaller than terbinafine
- Best fit
- Adults with lab-confirmed dermatophyte toenail infection and no heart failure
- Time
- Cure was assessed months after treatment ended (72 weeks in LION) as the nail grows out
blastomycosis and histoplasmosis
- Effect
- Success in 81% to 90% of treated patients, without a control group
- Best fit
- Adults with non-meningeal, non-life-threatening blastomycosis or histoplasmosis
- Time
- Successful patients were treated for a median of 6.2 months (blastomycosis) and 9.0 months (histoplasmosis)
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
fungal nail infection of the toenails
Disease adjunctA Cochrane review of 48 trials with 10,200 people found high-quality evidence that azole antifungals, the drug group that includes itraconazole, were more effective than placebo for clinical cure (risk ratio 22.18) and mycological cure (risk ratio 5.86), with probably no significant difference in side effects. Terbinafine was probably more effective than azoles (moderate-quality evidence). In the LION trial of 496 adults, pulse itraconazole (400 mg a day for 1 week in every 4) gave mycological cure at 72 weeks in 38.3% (3 pulses) and 49.1% (4 pulses), versus 75.7% and 80.8% with 12 or 16 weeks of terbinafine.
Bottom line: Itraconazole clears toenail fungus far better than placebo, but terbinafine usually works better.
Evidence is mixed
Head-to-head, continuous terbinafine beat pulse itraconazole in the LION trial and probably beats azoles overall in the Cochrane review.
blastomycosis and histoplasmosis
Disease adjunctIn a nonrandomized open multicenter study of the NIAID Mycoses Study Group, 85 patients with non-meningeal, non-life-threatening blastomycosis (48) or histoplasmosis (37) took itraconazole 200 to 400 mg a day. Treatment succeeded in 90% with blastomycosis (95% of those treated more than 2 months) and 81% with histoplasmosis (86% of those treated more than 2 months); all histoplasmosis failures had chronic cavitary lung disease. Side effects occurred in 29%, and only 1 patient stopped because of them. There was no comparison group.
Bottom line: Itraconazole treated most mild to moderate blastomycosis and histoplasmosis cases in an uncontrolled trial.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; take capsules right after a full meal, report heart or liver symptoms at once, and check every other medicine and supplement first.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Congestive heart failure (boxed warning). Itraconazole weakens heart muscle contraction and has been linked to heart failure, swelling and fluid in the lungs. Capsules should not be used for nail infections in people with heart failure or a history of it, and for other infections only if the benefit clearly outweighs the risk. Calcium channel blockers can add to this effect.
Drug interactions (boxed warning). Many drugs cleared by CYP3A4 are contraindicated because itraconazole raises their levels, which for some can cause QT prolongation and torsade de pointes, a potentially fatal heart rhythm. Life-threatening rhythm problems and sudden death have occurred with drugs such as cisapride, pimozide, methadone and quinidine.
Rare serious liver injury, including liver failure and death, sometimes in people without prior liver disease and sometimes within the first week. The label recommends considering liver tests in everyone taking it.
Nerve damage (neuropathy), transient or permanent hearing loss (several reports involved quinidine, which is contraindicated), and pseudoaldosteronism with new or worse high blood pressure and low potassium.
Who should avoid it
- People with ventricular dysfunction such as congestive heart failure, or a history of it, when treating a nail infection (contraindicated)
- People taking a contraindicated CYP3A4 drug, such as methadone, disopyramide, dofetilide, dronedarone, quinidine, ergot alkaloids, lurasidone, oral midazolam, pimozide, triazolam, felodipine, nisoldipine, ivabradine, ranolazine, eplerenone, lovastatin, simvastatin, avanafil, ticagrelor or finerenone
- Pregnant women and women planning a pregnancy, when treating a nail infection (contraindicated)
- People who have had an allergic reaction to itraconazole (contraindicated)
Pregnancy & breastfeeding
Pregnancy: the Sporanox label says it caused birth defects in rats and mice, that there are no studies in pregnant women, and that cases of congenital abnormalities have been reported after marketing. It should be used for systemic fungal infections in pregnancy only if the benefit outweighs the risk, and must not be used for nail infections in pregnant women or women planning pregnancy; women who could become pregnant should use effective contraception during treatment and for 2 months afterward. The Tolsura label adds that published studies of short first-trimester courses reported no overall increase in major birth defects and inconclusive findings on miscarriage. Breastfeeding: both labels say itraconazole passes into human milk; the Sporanox label says to weigh the benefit to the mother against the risk to the infant, and the Tolsura label says there are no data on the amount in milk or effects on the breastfed child.
Interactions
The boxed warning says itraconazole raises the levels of these drugs, which can lead to QT prolongation and potentially fatal heart rhythms or other serious effects; they must not be combined. Some, such as ticagrelor, are contraindicated for 2 weeks after itraconazole ends as well. Show every prescriber and pharmacist your full medicine list before starting.
Saccharomyces boulardii is a live yeast probiotic. The Sporanox and Tolsura labels list it among products whose effect itraconazole may reduce and say it is not recommended during treatment and for 2 weeks after. The safety study cited here did not test itraconazole: in five Finnish university hospitals, at least 20 of 46 people with Saccharomyces bloodstream infection had been using an S. boulardii probiotic, and 59% of the 46 had a digestive tract disease. Tell your prescriber if you take it and ask what to do during treatment.
The label says these lower itraconazole levels and may make it fail, and that they are not recommended from 2 weeks before and during treatment (and for rifabutin and carbamazepine, also for 2 weeks after). Ask your prescriber before combining them.
Study results are mixed and depend on the form, and all three studies were in healthy volunteers. In 11 volunteers, grapefruit juice taken with itraconazole capsules lowered itraconazole exposure by 43%; another study of 22 men found no effect of grapefruit juice on a single 100 mg dose. With the oral solution, repeated grapefruit juice raised exposure by about 17% to 20%. Avoid taking your doses with grapefruit juice, keep your intake steady, and ask your pharmacist if you drink it often.
Capsules need stomach acid to be absorbed. The label says to use these with caution and to take acid-neutralizing antacids at least 2 hours before or 2 hours after the capsules; in people with low stomach acid, taking capsules with a non-diet cola increased absorption in label studies. Ask your prescriber how to handle acid medicines during treatment.
In a study of 22 healthy men given a single dose of itraconazole, orange juice lowered total itraconazole exposure by an average of 41% and shortened its half-life by 56% compared with mineral water. The itraconazole labels do not mention orange juice, and treatment outcomes were not measured. Take your doses with water or another drink your pharmacist recommends.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (2)
+ grapefruit
moderateStudy results with grapefruit juice are mixed and depend on the form of itraconazole, and all three studies were in healthy volunteers. In 11 volunteers, grapefruit juice taken with itraconazole capsules lowered itraconazole exposure by 43%; in 22 men given a single 100 mg dose, grapefruit juice had no effect; with the oral solution, repeated grapefruit juice raised exposure by about 17% to 20%. Why grapefruit lowered exposure with capsules is not established.
+ orange juice
moderateIn a study of 22 healthy men given a single dose of itraconazole, orange juice lowered total itraconazole exposure (AUC) by an average of 41% and shortened its half-life by 56% compared with mineral water, while grapefruit juice had no effect. Lower levels could weaken treatment, but outcomes were not measured, the cause was not established, and the itraconazole labels do not mention orange juice.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I drink grapefruit juice with itraconazole?⌄
Avoid taking your dose with it. This page rates grapefruit juice a moderate interaction: it lowered levels from capsules by 43% in one small study, had no effect in another, and slightly raised levels from the oral solution. Keep your intake steady and ask your pharmacist if you drink it often.
Can I keep taking my Saccharomyces boulardii probiotic?⌄
Ask your prescriber first. This page rates it a high-severity interaction. The itraconazole labels say Saccharomyces boulardii is not recommended during treatment and for 2 weeks after, because the antifungal may reduce its effect. The live yeast has also caused bloodstream infections, mostly reported in hospital patients, many with digestive tract disease.
Should I take itraconazole with food?⌄
It depends on the form. The label says Sporanox and generic capsules are best absorbed right after a full meal, and Tolsura must be taken with food. The oral solution is taken without food if possible. Check your pharmacy label.
Why does my pharmacist ask about all my medicines?⌄
Itraconazole's boxed warning lists many drugs that must not be combined with it, including some cholesterol, sleep, heart-rhythm and pain medicines, because it raises their levels and can cause dangerous heart rhythms. Some interactions continue for up to 2 weeks after the last dose.
What heart symptoms should I watch for?⌄
The label warns that itraconazole can cause or worsen heart failure. Call your prescriber right away for shortness of breath, swelling in the feet, ankles or legs, sudden weight gain, unusual tiredness, or coughing up white or pink mucus.
References by claim
Track Itraconazole with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
